AU2001267844A1 - Method of preparing heart muscle cells and method of searching for remedy for heart diseases - Google Patents

Method of preparing heart muscle cells and method of searching for remedy for heart diseases

Info

Publication number
AU2001267844A1
AU2001267844A1 AU2001267844A AU6784401A AU2001267844A1 AU 2001267844 A1 AU2001267844 A1 AU 2001267844A1 AU 2001267844 A AU2001267844 A AU 2001267844A AU 6784401 A AU6784401 A AU 6784401A AU 2001267844 A1 AU2001267844 A1 AU 2001267844A1
Authority
AU
Australia
Prior art keywords
heart muscle
heart
muscle cells
cells
apoptosis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001267844A
Inventor
Hisao Hirota
Hideharu Kimura
Tadamitsu Kishimoto
Nobuyuki Koyama
Keiko Takihara
Seiichi Tanida
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Takeda Pharmaceutical Co Ltd
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Publication of AU2001267844A1 publication Critical patent/AU2001267844A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
    • G01N33/5061—Muscle cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0657—Cardiomyocytes; Heart cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2503/00—Use of cells in diagnostics
    • C12N2503/02—Drug screening
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2509/00—Methods for the dissociation of cells, e.g. specific use of enzymes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2510/00—Detection of programmed cell death, i.e. apoptosis
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/32—Cardiovascular disorders
    • G01N2800/324—Coronary artery diseases, e.g. angina pectoris, myocardial infarction

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Cell Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Genetics & Genomics (AREA)
  • Urology & Nephrology (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Cardiology (AREA)
  • General Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Pathology (AREA)
  • General Engineering & Computer Science (AREA)
  • Toxicology (AREA)
  • Rheumatology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

The present invention relates to a method of preparing primary heart muscle cells, characterized by washing a fine fragmented heart tissue with a phosphate-buffered physiological saline to thereby eliminate non-heart muscle cells and then hemolyzing the heart tissue digested with a protease to thereby eliminate erythrocytes. According to this method, highly pure primary heart muscle cells can be conveniently obtained in a large amount from the heart of an animal embryo or newborn. By using the heart muscle thus prepared, apoptosis of heart muscle cells can be efficiently and highly sensitively detected. Thus, it is possible to efficiently screen candidate compounds for heart muscle cell apoptosis inhibitors, gp 130-mediated receptor agonists, heart muscle cell-protective signal enhancers, preventives and remedies for heart diseases. A method of detecting apoptosis comprises inducing apoptosis of heart muscle cells by incubating the cells in a serum-free medium, adding serum to the liquid culture medium thereof, then incubating the cells and counting viable heart muscle cells.
AU2001267844A 2000-06-28 2001-06-27 Method of preparing heart muscle cells and method of searching for remedy for heart diseases Abandoned AU2001267844A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2000-194805 2000-06-28
JP2000194805 2000-06-28
PCT/JP2001/005520 WO2002000850A1 (en) 2000-06-28 2001-06-27 Method of preparing heart muscle cells and method of searching for remedy for heart diseases

Publications (1)

Publication Number Publication Date
AU2001267844A1 true AU2001267844A1 (en) 2002-01-08

Family

ID=18693571

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001267844A Abandoned AU2001267844A1 (en) 2000-06-28 2001-06-27 Method of preparing heart muscle cells and method of searching for remedy for heart diseases

Country Status (6)

Country Link
US (2) US20030175847A1 (en)
EP (2) EP1295936B1 (en)
AT (1) ATE412766T1 (en)
AU (1) AU2001267844A1 (en)
DE (1) DE60136358D1 (en)
WO (1) WO2002000850A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004027014A1 (en) * 2002-09-17 2004-04-01 Japan Tissue Engineering Co.,Ltd Cell dispersing apparatus, cell dispersion cassette and tissue retention part
US8168718B2 (en) 2005-12-09 2012-05-01 Exxonmobil Chemical Patents Inc. Thermoplastic vulcanizate adhesive compositions
EP2226633A1 (en) * 2009-03-06 2010-09-08 Charité - Universitätsmedizin Berlin Uses and methods for the identification of a cytoprotective compound involving gp130 or LIFRalpha
CN108949673A (en) * 2018-08-13 2018-12-07 武汉华联科生物技术有限公司 A kind of primary separation method of Fetal Rat rat cardiomyocyte

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3948725A (en) * 1974-05-30 1976-04-06 Godo Shusei Kabushiki Kaisha Neutral protease useful for animal tissue and cell culture
JPH0372872A (en) * 1988-07-12 1991-03-28 Bio Kagaku Kenkyusho:Kk Serum-free culture medium and method for culturing cell of mammals using the same
US5543318A (en) * 1991-06-12 1996-08-06 Smith; David A. Method of isolation, culture and proliferation of human atrial myocytes
US5378698A (en) * 1991-10-21 1995-01-03 Shionogi & Co., Ltd. Benzothiazepine derivatives
US5919449A (en) * 1995-05-30 1999-07-06 Diacrin, Inc. Porcine cardiomyocytes and their use in treatment of insufficient cardiac function
US6133233A (en) * 1997-02-18 2000-10-17 Kansas State University Research Foundation Peptide modulation of reperfusion injury
WO1999011771A1 (en) * 1997-09-04 1999-03-11 Science Research Laboratory, Inc. Cell separation using electric fields
AU748334B2 (en) * 1997-10-16 2002-05-30 Board Of Regents, The University Of Texas System Models and treatments for cardiac hypertrophy in relation with NF-AT3 function

Also Published As

Publication number Publication date
EP1295936A1 (en) 2003-03-26
US20080160553A1 (en) 2008-07-03
EP2090663A2 (en) 2009-08-19
EP2090663A3 (en) 2009-11-11
DE60136358D1 (en) 2008-12-11
EP1295936A4 (en) 2004-11-10
EP1295936B1 (en) 2008-10-29
ATE412766T1 (en) 2008-11-15
US20030175847A1 (en) 2003-09-18
WO2002000850A1 (en) 2002-01-03

Similar Documents

Publication Publication Date Title
De Schauwer et al. In search for cross‐reactivity to immunophenotype equine mesenchymal stromal cells by multicolor flow cytometry
Tournadre et al. Immature muscle precursors are a source of interferon‐β in myositis: role of Toll‐like receptor 3 activation and contribution to HLA class I up‐regulation
Smith et al. Comparison of two methods for determining human adipose cell size
Hoeller et al. Epstein-Barr virus–positive diffuse large B-cell lymphoma in elderly patients is rare in Western populations
Riddell et al. An evaluation of three in vitro cytotoxicity assays
Higgs et al. Downregulation of Gadd45β expression by hepatitis C virus leads to defective cell cycle arrest
Kaieda et al. Synovial fibroblasts promote the expression and granule accumulation of tryptase via interleukin-33 and its receptor ST-2 (IL1RL1)
Grossfeld et al. Differentiation of fibroblasts in tissue culture, as determined by mucopolysaccharide production.
McDonald et al. External potassium and baby hamster kidney cells: intracellular ions, ATP, growth, DNA synthesis and membrane potential
Lee et al. Isolation and expansion of synovial CD34− CD44+ CD90+ mesenchymal stem cells: comparison of an enzymatic method and a direct explant technique
US10935542B2 (en) Method for identification and culture of multipotent mesenchymal stem cells with high proliferation potential
Fu et al. Beneficial effect of human umbilical cord‑derived mesenchymal stem cells on an endotoxin‑induced rat model of preeclampsia
Qiu et al. IL-2 and IL-27 synergistically promote growth and invasion of endometriotic stromal cells by maintaining the balance of IFN-γ and IL-10 in endometriosis
Hiden et al. Membrane-type matrix metalloproteinase 1 regulates trophoblast functions and is reduced in fetal growth restriction
CN110231275A (en) A method of based on Flow cytometry NK cell killing activity
Dolbeare et al. A fluorescent assay of proteinases in cultured mammalian cells.
CA3017823A1 (en) An ex-vivo intestinal culture model, methods of producing same and uses thereof
EP2090663A3 (en) Method of preparing heart muscle cells and method of searching for remedy for heart diseases
Robl et al. Effects of serum on swine morulae and blastocysts in vitro
Pham et al. A simple in vitro method for evaluating dendritic cell-based vaccinations
Dropcova et al. A standard strain of human ocular keratocytes
Biron‐Andréani et al. Secretion of functional plasma haemostasis proteins in long‐term primary cultures of human hepatocytes
EE200000763A (en) Detection of non-fertile egg cells
Choi et al. Relationships between cytokine levels and disease parameters during the development of a collagen-induced arthritis model in cynomolgus macaques (Macaca fascicularis)
Wei et al. Biological characteristics of two mesenchymal stem cell cultures isolated from the umbilical cord and adipose tissue of a neonatal common hippo (Hippopotamus amphibius)